The ketamine product KETARx produced by PharmaTher has been approved by the FDA for use in surgical pain management.

Semaglutide was not linked to eye disorders or retinopathy, but it was associated with a higher risk for NAION.

Saliva insulin levels were indicative of differences between normal and hyperinsulinemic responses in normoglycemic individuals.

Phil and Penny Knight will donate $2 billion to the Knight Cancer Institute at Oregon Health and Science University.

Adherence to a healthier lifestyle after initial colonoscopy screening is associated with a decreased risk for colorectal cancer.

Positive associations were seen for celiac disease, SLE, and T1D with pancreatic, esophageal, colon, liver, and hepatobiliary cancers.

A cholera outbreak in Sudan’s Darfur region killed 40 people and infected more than 2,300 in a single week, the worst in years.

The AHA and the ACC have jointly released an updated guideline on the prevention and management of high blood pressure in adults.

A high continuous metabolic syndrome severity score trajectory pattern was linked to increased risk for CKD in adjusted analyses.

The FDA has granted accelerated approval for Wegovy for the treatment of noncirrhotic MASH with moderate to advanced liver fibrosis in adults.

Glucagon-like peptide 1 receptor agonist injectable use was 26.5% in 2024 nationally among adults diagnosed with diabetes.

While patients with early-stage hepatocellular carcinoma (HCC) have a risk for death from liver-related complications and nonliver illness, HCC-related mortality is the most common cause of death, ...